Or you can use the BCBS Find a Doctor tool or Provider Locator on their website
Even more concerning, some individuals experience: Gallbladder issues Pancreatitis Malnutrition from chronic nausea and reduced food intake Rebound weight gain if the medication is stopped And perhaps most problematic: semaglutide doesnt teach your body how to metabolize properlyit just suppresses hunger signals
Over time, it may slow down cognitive decline and boost heart health
TMAO promotes apoptosis and oxidative stress of pancreatic acinar cells by mediating IRE1-XBP-1 pathway
Our integrated approach has led to more than 96% of Oshi patients on GLP-1s reporting improvement and control over their symptoms within six months of starting care, which led to better reported quality of life and increased medication adherence
- Todd Brown Review (03/10/26) Initiating Semaglutide Therapy Reduces Tobacco Cigarette use among People with HIV - (03/07/26) Tirzepatide use in People with HIV Shows Effectiveness for Weight Loss and Diabetic Control - (03/07/26) Real-World Outcomes of Tirzepatide Use in People With HIV With and Without Diabetes - (03/07/26) Evaluation of GLP-1 Medications in an Observational Cohort of People with HIV in Washington, DC (2011-2025) - (03/07/26) Effects of Semaglutide on Subclinical Cardiovascular Health in People With HIV - (03/07/26) The Impact of Semaglutide on Depressive Symptoms Among People With HIV - (02/27/26) Jimmy Ma1, Stephanie A
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
